孟鲁司特联合舒利迭治疗支气管哮喘急性发作的临床效果

打开文本图片集

【摘要】目的：分析孟鲁司特联合舒利迭对支气管哮喘急性发作的临床效果。方法：选取我院2020年1月—2023年1月的120例支气管哮喘急性发作患者，随机将其分成为两组。对照组单用舒利迭，观察组联用孟鲁司特。结果：观察组的有效率明显高于对照组（P0.05），治疗后，两组的咳嗽、食欲不振、喘憋和呼吸困难评分均明显降低（P0.05），治疗后，两组的FEV1/FVC、MVV、MMF和PEF均明显改善（P

【关键词】孟鲁司特；舒利迭；急性发作；支气管哮喘

Clinical effect of montelukast combined with seretide on acute attack of bronchial asthma

WU Weijuan

The First People ’s Hospital of Longxi County， Dingxi， Gansu 748100， China

【Abstract】Objective：To analyze the clinical effect of montelukast combined with seretide on acute attack of bronchial asthma. Methods：120 patients with acute attack of bronchial asthma in our hospital from January 2020 to January 2023 were randomly divided into two groups. The control group was treated with seretide alone， and the observation group was treated with montelukast. Results：The effective rate of the observation group was significantly higher than that of the control group （P 0.05）. After treatment， the scores of cough， chest and diaphragm fullness， expectoration， inappetence， asthma and dyspnea in the two groups were significantly reduced （P 0.05）， after treatment， FEV1/FVC， MVV， MMF and PEF of the two groups improved significantly （P

【Key Words】Montelukast； Seretide； Acute attack； Bronchial asthma

支气管哮喘作为一种慢性反复发作性的气道炎性疾病，患者主要表现为气短、剧烈喘息、咳嗽和胸闷等，其发生可能与变态反应、气道慢性炎症反应、气道高反应性以及遗传机制等紧密相关，若未及时治疗会引起呼吸抑制，甚至会危及患者的生命[1]。（剩余4092字）